Sector consensus Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 16:00:02 2025-06-23 EDT			After hours 17:47:54
80.16 ^USD	+1.39%		79.81	-0.44%

09:22am	Merck's Pulmonary Arterial Hypertension Drug Meets Primary Endpoint	DJ
08:29am	Merck: new positive Phase 3 results in PAH	CF

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Average Target P.	Ecart obj. / dr	Nbr of analysts
MERCK & CO., INC.		US$101.79	+28.75%	24
ELI LILLY AND COMPANY		US$951.98	+24.81%	27
JOHNSON & JOHNSON		US$169.18	+12.95%	23
ABBVIE INC.		US$208.86	+12.72%	27
NOVO NORDISK A/S		DKK 662.18	+39.17%	22
ROCHE HOLDING AG		CHF 302.63	+16.71%	20
NOVARTIS AG	-	CHF 118.73	+2.24%	19
ASTRAZENECA PLC		GBX 179.12	+27.96%	20
AMGEN INC.		US$314.7	+8.77%	28
PFIZER, INC.		US$29.24	+21.98%	23
GILEAD SCIENCES, INC.		US$116.77	+7.62%	26
SANOFI		€114.73	+37.86%	23
VERTEX PHARMACEUTICALS INCORPORATED		US$499.87	+13.38%	28
BRISTOL-MYERS SQUIBB COMPANY		US$57.1	+21.84%	22
CHUGAI PHARMACEUTICAL CO., LTD.		JP¥8,303.57	+10.57%	14
GSK PLC		GBX 16.66	+18.81%	19
JIANGSU HENGRUI MEDICINE CO., LTD.		CN¥64.5	+24.13%	16
HALEON PLC		GBX 4.247	+10.46%	17
TAKEDA PHARMACEUTICAL COMPANY LIMITED		JP¥4,946.56	+15.47%	16
Average		903.29	+18.75%	22
Weighted average by Cap.		605.98	+20.07%	23